nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—CYP2C9—Leflunomide—systemic scleroderma	0.0986	0.563	CbGbCtD
Tenoxicam—SLC22A8—Methotrexate—systemic scleroderma	0.0764	0.436	CbGbCtD
Tenoxicam—CYP2C9—cardial valve—systemic scleroderma	0.0728	0.388	CbGeAlD
Tenoxicam—PTGS2—skeletal joint—systemic scleroderma	0.0228	0.121	CbGeAlD
Tenoxicam—PTGS1—artery—systemic scleroderma	0.00997	0.0532	CbGeAlD
Tenoxicam—PTGS2—artery—systemic scleroderma	0.00953	0.0508	CbGeAlD
Tenoxicam—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00865	0.624	CbGdCrCtD
Tenoxicam—PTGS1—endothelium—systemic scleroderma	0.00842	0.0449	CbGeAlD
Tenoxicam—PTGS2—endothelium—systemic scleroderma	0.00805	0.0429	CbGeAlD
Tenoxicam—PTGS1—blood vessel—systemic scleroderma	0.00777	0.0414	CbGeAlD
Tenoxicam—PTGS2—blood vessel—systemic scleroderma	0.00742	0.0396	CbGeAlD
Tenoxicam—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00522	0.376	CbGdCrCtD
Tenoxicam—PTGS1—connective tissue—systemic scleroderma	0.00398	0.0212	CbGeAlD
Tenoxicam—PTGS2—connective tissue—systemic scleroderma	0.00381	0.0203	CbGeAlD
Tenoxicam—PTGS1—smooth muscle tissue—systemic scleroderma	0.00364	0.0194	CbGeAlD
Tenoxicam—PTGS1—skin of body—systemic scleroderma	0.0036	0.0192	CbGeAlD
Tenoxicam—PTGS2—smooth muscle tissue—systemic scleroderma	0.00348	0.0186	CbGeAlD
Tenoxicam—PTGS2—skin of body—systemic scleroderma	0.00344	0.0183	CbGeAlD
Tenoxicam—CYP2C9—digestive system—systemic scleroderma	0.00315	0.0168	CbGeAlD
Tenoxicam—PTGS1—digestive system—systemic scleroderma	0.00288	0.0153	CbGeAlD
Tenoxicam—PTGS2—digestive system—systemic scleroderma	0.00275	0.0147	CbGeAlD
Tenoxicam—PTGS1—tendon—systemic scleroderma	0.00274	0.0146	CbGeAlD
Tenoxicam—PTGS2—tendon—systemic scleroderma	0.00262	0.014	CbGeAlD
Tenoxicam—PTGS1—lung—systemic scleroderma	0.0024	0.0128	CbGeAlD
Tenoxicam—PTGS2—lung—systemic scleroderma	0.0023	0.0122	CbGeAlD
Tenoxicam—Anaemia—Leflunomide—systemic scleroderma	0.00171	0.00274	CcSEcCtD
Tenoxicam—Angioedema—Leflunomide—systemic scleroderma	0.00169	0.00271	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00169	0.0027	CcSEcCtD
Tenoxicam—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00267	CcSEcCtD
Tenoxicam—Vertigo—Leflunomide—systemic scleroderma	0.00166	0.00266	CcSEcCtD
Tenoxicam—Angiopathy—Lisinopril—systemic scleroderma	0.00166	0.00266	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00166	0.00266	CcSEcCtD
Tenoxicam—Leukopenia—Leflunomide—systemic scleroderma	0.00166	0.00265	CcSEcCtD
Tenoxicam—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00165	0.00265	CcSEcCtD
Tenoxicam—Palpitations—Leflunomide—systemic scleroderma	0.00163	0.00262	CcSEcCtD
Tenoxicam—Dyspnoea—Captopril—systemic scleroderma	0.00163	0.00262	CcSEcCtD
Tenoxicam—Anaemia—Mycophenolic acid—systemic scleroderma	0.00163	0.00262	CcSEcCtD
Tenoxicam—Dyspepsia—Captopril—systemic scleroderma	0.00161	0.00259	CcSEcCtD
Tenoxicam—Cardiac failure—Prednisone—systemic scleroderma	0.00161	0.00258	CcSEcCtD
Tenoxicam—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.0016	0.00257	CcSEcCtD
Tenoxicam—Mental disorder—Lisinopril—systemic scleroderma	0.0016	0.00256	CcSEcCtD
Tenoxicam—Dizziness—Pentoxifylline—systemic scleroderma	0.0016	0.00256	CcSEcCtD
Tenoxicam—Decreased appetite—Captopril—systemic scleroderma	0.00159	0.00255	CcSEcCtD
Tenoxicam—Erythema—Lisinopril—systemic scleroderma	0.00159	0.00255	CcSEcCtD
Tenoxicam—Malnutrition—Lisinopril—systemic scleroderma	0.00159	0.00255	CcSEcCtD
Tenoxicam—Vertigo—Mycophenolic acid—systemic scleroderma	0.00159	0.00254	CcSEcCtD
Tenoxicam—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00253	CcSEcCtD
Tenoxicam—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00158	0.00253	CcSEcCtD
Tenoxicam—Fatigue—Captopril—systemic scleroderma	0.00158	0.00253	CcSEcCtD
Tenoxicam—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00251	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00157	0.00251	CcSEcCtD
Tenoxicam—Constipation—Captopril—systemic scleroderma	0.00157	0.00251	CcSEcCtD
Tenoxicam—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00157	0.00251	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00156	0.00251	CcSEcCtD
Tenoxicam—Palpitations—Mycophenolic acid—systemic scleroderma	0.00156	0.0025	CcSEcCtD
Tenoxicam—Skin disorder—Azathioprine—systemic scleroderma	0.00155	0.00249	CcSEcCtD
Tenoxicam—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00247	CcSEcCtD
Tenoxicam—Dry mouth—Leflunomide—systemic scleroderma	0.00154	0.00247	CcSEcCtD
Tenoxicam—Vomiting—Pentoxifylline—systemic scleroderma	0.00154	0.00246	CcSEcCtD
Tenoxicam—Rash—Pentoxifylline—systemic scleroderma	0.00152	0.00244	CcSEcCtD
Tenoxicam—Dermatitis—Pentoxifylline—systemic scleroderma	0.00152	0.00244	CcSEcCtD
Tenoxicam—Headache—Pentoxifylline—systemic scleroderma	0.00151	0.00243	CcSEcCtD
Tenoxicam—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00151	0.00242	CcSEcCtD
Tenoxicam—Asthenia—Mometasone—systemic scleroderma	0.0015	0.0024	CcSEcCtD
Tenoxicam—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00149	0.0024	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00149	0.00239	CcSEcCtD
Tenoxicam—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00238	CcSEcCtD
Tenoxicam—Nervous system disorder—Leflunomide—systemic scleroderma	0.00148	0.00237	CcSEcCtD
Tenoxicam—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00148	0.00237	CcSEcCtD
Tenoxicam—Pruritus—Mometasone—systemic scleroderma	0.00148	0.00237	CcSEcCtD
Tenoxicam—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00147	0.00236	CcSEcCtD
Tenoxicam—Anaemia—Lisinopril—systemic scleroderma	0.00147	0.00236	CcSEcCtD
Tenoxicam—Skin disorder—Leflunomide—systemic scleroderma	0.00147	0.00235	CcSEcCtD
Tenoxicam—Angioedema—Lisinopril—systemic scleroderma	0.00145	0.00233	CcSEcCtD
Tenoxicam—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00233	CcSEcCtD
Tenoxicam—Oedema—Mycophenolic acid—systemic scleroderma	0.00144	0.00231	CcSEcCtD
Tenoxicam—Anorexia—Leflunomide—systemic scleroderma	0.00144	0.00231	CcSEcCtD
Tenoxicam—Nausea—Pentoxifylline—systemic scleroderma	0.00144	0.0023	CcSEcCtD
Tenoxicam—Vertigo—Lisinopril—systemic scleroderma	0.00143	0.00229	CcSEcCtD
Tenoxicam—Diarrhoea—Mometasone—systemic scleroderma	0.00143	0.00229	CcSEcCtD
Tenoxicam—Leukopenia—Lisinopril—systemic scleroderma	0.00142	0.00228	CcSEcCtD
Tenoxicam—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00141	0.00226	CcSEcCtD
Tenoxicam—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00141	0.00226	CcSEcCtD
Tenoxicam—Palpitations—Lisinopril—systemic scleroderma	0.0014	0.00225	CcSEcCtD
Tenoxicam—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00225	CcSEcCtD
Tenoxicam—Skin disorder—Mycophenolic acid—systemic scleroderma	0.0014	0.00224	CcSEcCtD
Tenoxicam—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00223	CcSEcCtD
Tenoxicam—Visual disturbance—Methotrexate—systemic scleroderma	0.00138	0.00222	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00138	0.00221	CcSEcCtD
Tenoxicam—Anorexia—Mycophenolic acid—systemic scleroderma	0.00137	0.0022	CcSEcCtD
Tenoxicam—Dyspnoea—Leflunomide—systemic scleroderma	0.00135	0.00216	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00134	0.00215	CcSEcCtD
Tenoxicam—Dyspepsia—Leflunomide—systemic scleroderma	0.00133	0.00213	CcSEcCtD
Tenoxicam—Vomiting—Mometasone—systemic scleroderma	0.00133	0.00213	CcSEcCtD
Tenoxicam—Dry mouth—Lisinopril—systemic scleroderma	0.00132	0.00212	CcSEcCtD
Tenoxicam—Rash—Mometasone—systemic scleroderma	0.00131	0.00211	CcSEcCtD
Tenoxicam—Asthenia—Captopril—systemic scleroderma	0.00131	0.00211	CcSEcCtD
Tenoxicam—Dermatitis—Mometasone—systemic scleroderma	0.00131	0.00211	CcSEcCtD
Tenoxicam—Decreased appetite—Leflunomide—systemic scleroderma	0.00131	0.0021	CcSEcCtD
Tenoxicam—Headache—Mometasone—systemic scleroderma	0.00131	0.00209	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.0013	0.00209	CcSEcCtD
Tenoxicam—Fatigue—Leflunomide—systemic scleroderma	0.0013	0.00209	CcSEcCtD
Tenoxicam—Anaphylactic shock—Lisinopril—systemic scleroderma	0.0013	0.00208	CcSEcCtD
Tenoxicam—Oedema—Lisinopril—systemic scleroderma	0.0013	0.00208	CcSEcCtD
Tenoxicam—Pruritus—Captopril—systemic scleroderma	0.0013	0.00208	CcSEcCtD
Tenoxicam—Constipation—Leflunomide—systemic scleroderma	0.00129	0.00207	CcSEcCtD
Tenoxicam—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00206	CcSEcCtD
Tenoxicam—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00128	0.00206	CcSEcCtD
Tenoxicam—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00204	CcSEcCtD
Tenoxicam—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00127	0.00204	CcSEcCtD
Tenoxicam—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00127	0.00203	CcSEcCtD
Tenoxicam—Skin disorder—Lisinopril—systemic scleroderma	0.00126	0.00202	CcSEcCtD
Tenoxicam—Diarrhoea—Captopril—systemic scleroderma	0.00125	0.00201	CcSEcCtD
Tenoxicam—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00125	0.00201	CcSEcCtD
Tenoxicam—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00201	CcSEcCtD
Tenoxicam—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.002	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00124	0.00199	CcSEcCtD
Tenoxicam—Fatigue—Mycophenolic acid—systemic scleroderma	0.00124	0.00199	CcSEcCtD
Tenoxicam—Nausea—Mometasone—systemic scleroderma	0.00124	0.00199	CcSEcCtD
Tenoxicam—Anorexia—Lisinopril—systemic scleroderma	0.00124	0.00198	CcSEcCtD
Tenoxicam—Constipation—Mycophenolic acid—systemic scleroderma	0.00123	0.00197	CcSEcCtD
Tenoxicam—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00197	CcSEcCtD
Tenoxicam—Dizziness—Captopril—systemic scleroderma	0.00121	0.00194	CcSEcCtD
Tenoxicam—Urticaria—Leflunomide—systemic scleroderma	0.0012	0.00192	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00119	0.00191	CcSEcCtD
Tenoxicam—Myocardial infarction—Prednisone—systemic scleroderma	0.00118	0.0019	CcSEcCtD
Tenoxicam—Breast disorder—Methotrexate—systemic scleroderma	0.00118	0.0019	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00118	0.00189	CcSEcCtD
Tenoxicam—Hypersensitivity—Azathioprine—systemic scleroderma	0.00118	0.00189	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00189	CcSEcCtD
Tenoxicam—Vomiting—Captopril—systemic scleroderma	0.00116	0.00187	CcSEcCtD
Tenoxicam—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00186	CcSEcCtD
Tenoxicam—Dyspnoea—Lisinopril—systemic scleroderma	0.00116	0.00185	CcSEcCtD
Tenoxicam—Rash—Captopril—systemic scleroderma	0.00115	0.00185	CcSEcCtD
Tenoxicam—Dermatitis—Captopril—systemic scleroderma	0.00115	0.00185	CcSEcCtD
Tenoxicam—Headache—Captopril—systemic scleroderma	0.00115	0.00184	CcSEcCtD
Tenoxicam—Dyspepsia—Lisinopril—systemic scleroderma	0.00114	0.00183	CcSEcCtD
Tenoxicam—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00182	CcSEcCtD
Tenoxicam—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00182	CcSEcCtD
Tenoxicam—Asthma—Methotrexate—systemic scleroderma	0.00113	0.00182	CcSEcCtD
Tenoxicam—Decreased appetite—Lisinopril—systemic scleroderma	0.00113	0.00181	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00112	0.0018	CcSEcCtD
Tenoxicam—Fatigue—Lisinopril—systemic scleroderma	0.00112	0.00179	CcSEcCtD
Tenoxicam—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00179	CcSEcCtD
Tenoxicam—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00178	CcSEcCtD
Tenoxicam—Hypersensitivity—Leflunomide—systemic scleroderma	0.00111	0.00178	CcSEcCtD
Tenoxicam—Constipation—Lisinopril—systemic scleroderma	0.00111	0.00178	CcSEcCtD
Tenoxicam—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00177	CcSEcCtD
Tenoxicam—Diarrhoea—Azathioprine—systemic scleroderma	0.00109	0.00175	CcSEcCtD
Tenoxicam—Nausea—Captopril—systemic scleroderma	0.00109	0.00174	CcSEcCtD
Tenoxicam—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00109	0.00174	CcSEcCtD
Tenoxicam—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00174	CcSEcCtD
Tenoxicam—Asthenia—Leflunomide—systemic scleroderma	0.00108	0.00174	CcSEcCtD
Tenoxicam—Pruritus—Leflunomide—systemic scleroderma	0.00107	0.00171	CcSEcCtD
Tenoxicam—Dizziness—Azathioprine—systemic scleroderma	0.00106	0.00169	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00103	0.00166	CcSEcCtD
Tenoxicam—Asthenia—Mycophenolic acid—systemic scleroderma	0.00103	0.00166	CcSEcCtD
Tenoxicam—Diarrhoea—Leflunomide—systemic scleroderma	0.00103	0.00166	CcSEcCtD
Tenoxicam—Urticaria—Lisinopril—systemic scleroderma	0.00103	0.00165	CcSEcCtD
Tenoxicam—Pruritus—Mycophenolic acid—systemic scleroderma	0.00102	0.00163	CcSEcCtD
Tenoxicam—Vomiting—Azathioprine—systemic scleroderma	0.00102	0.00163	CcSEcCtD
Tenoxicam—Eye disorder—Prednisone—systemic scleroderma	0.00101	0.00162	CcSEcCtD
Tenoxicam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00162	CcSEcCtD
Tenoxicam—Rash—Azathioprine—systemic scleroderma	0.00101	0.00162	CcSEcCtD
Tenoxicam—Dermatitis—Azathioprine—systemic scleroderma	0.00101	0.00161	CcSEcCtD
Tenoxicam—Headache—Azathioprine—systemic scleroderma	0.001	0.00161	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.001	0.0016	CcSEcCtD
Tenoxicam—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.001	0.0016	CcSEcCtD
Tenoxicam—Dizziness—Leflunomide—systemic scleroderma	0.000998	0.0016	CcSEcCtD
Tenoxicam—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000988	0.00158	CcSEcCtD
Tenoxicam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000985	0.00158	CcSEcCtD
Tenoxicam—Stomatitis—Methotrexate—systemic scleroderma	0.000984	0.00158	CcSEcCtD
Tenoxicam—Angiopathy—Prednisone—systemic scleroderma	0.000984	0.00158	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000981	0.00157	CcSEcCtD
Tenoxicam—Immune system disorder—Prednisone—systemic scleroderma	0.000979	0.00157	CcSEcCtD
Tenoxicam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000972	0.00156	CcSEcCtD
Tenoxicam—Vomiting—Leflunomide—systemic scleroderma	0.00096	0.00154	CcSEcCtD
Tenoxicam—Hypersensitivity—Lisinopril—systemic scleroderma	0.000956	0.00153	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000955	0.00153	CcSEcCtD
Tenoxicam—Dizziness—Mycophenolic acid—systemic scleroderma	0.000952	0.00153	CcSEcCtD
Tenoxicam—Rash—Leflunomide—systemic scleroderma	0.000952	0.00153	CcSEcCtD
Tenoxicam—Dermatitis—Leflunomide—systemic scleroderma	0.000951	0.00152	CcSEcCtD
Tenoxicam—Mental disorder—Prednisone—systemic scleroderma	0.00095	0.00152	CcSEcCtD
Tenoxicam—Nausea—Azathioprine—systemic scleroderma	0.000949	0.00152	CcSEcCtD
Tenoxicam—Headache—Leflunomide—systemic scleroderma	0.000946	0.00152	CcSEcCtD
Tenoxicam—Erythema—Prednisone—systemic scleroderma	0.000944	0.00151	CcSEcCtD
Tenoxicam—Malnutrition—Prednisone—systemic scleroderma	0.000944	0.00151	CcSEcCtD
Tenoxicam—Agranulocytosis—Methotrexate—systemic scleroderma	0.000942	0.00151	CcSEcCtD
Tenoxicam—Asthenia—Lisinopril—systemic scleroderma	0.000931	0.00149	CcSEcCtD
Tenoxicam—Pruritus—Lisinopril—systemic scleroderma	0.000918	0.00147	CcSEcCtD
Tenoxicam—Vomiting—Mycophenolic acid—systemic scleroderma	0.000916	0.00147	CcSEcCtD
Tenoxicam—Rash—Mycophenolic acid—systemic scleroderma	0.000908	0.00146	CcSEcCtD
Tenoxicam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000907	0.00145	CcSEcCtD
Tenoxicam—Hepatitis—Methotrexate—systemic scleroderma	0.000906	0.00145	CcSEcCtD
Tenoxicam—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000903	0.00145	CcSEcCtD
Tenoxicam—Headache—Mycophenolic acid—systemic scleroderma	0.000902	0.00145	CcSEcCtD
Tenoxicam—Nausea—Leflunomide—systemic scleroderma	0.000897	0.00144	CcSEcCtD
Tenoxicam—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000895	0.00144	CcSEcCtD
Tenoxicam—Urethral disorder—Methotrexate—systemic scleroderma	0.000888	0.00142	CcSEcCtD
Tenoxicam—Diarrhoea—Lisinopril—systemic scleroderma	0.000887	0.00142	CcSEcCtD
Tenoxicam—Visual impairment—Methotrexate—systemic scleroderma	0.000873	0.0014	CcSEcCtD
Tenoxicam—Anaemia—Prednisone—systemic scleroderma	0.000872	0.0014	CcSEcCtD
Tenoxicam—Angioedema—Prednisone—systemic scleroderma	0.000862	0.00138	CcSEcCtD
Tenoxicam—Dizziness—Lisinopril—systemic scleroderma	0.000858	0.00138	CcSEcCtD
Tenoxicam—Erythema multiforme—Methotrexate—systemic scleroderma	0.000857	0.00137	CcSEcCtD
Tenoxicam—Nausea—Mycophenolic acid—systemic scleroderma	0.000855	0.00137	CcSEcCtD
Tenoxicam—Vertigo—Prednisone—systemic scleroderma	0.000848	0.00136	CcSEcCtD
Tenoxicam—Eye disorder—Methotrexate—systemic scleroderma	0.000847	0.00136	CcSEcCtD
Tenoxicam—Cardiac disorder—Methotrexate—systemic scleroderma	0.000841	0.00135	CcSEcCtD
Tenoxicam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000837	0.00134	CcSEcCtD
Tenoxicam—Vomiting—Lisinopril—systemic scleroderma	0.000825	0.00132	CcSEcCtD
Tenoxicam—Angiopathy—Methotrexate—systemic scleroderma	0.000822	0.00132	CcSEcCtD
Tenoxicam—Immune system disorder—Methotrexate—systemic scleroderma	0.000819	0.00131	CcSEcCtD
Tenoxicam—Rash—Lisinopril—systemic scleroderma	0.000818	0.00131	CcSEcCtD
Tenoxicam—Dermatitis—Lisinopril—systemic scleroderma	0.000817	0.00131	CcSEcCtD
Tenoxicam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000815	0.00131	CcSEcCtD
Tenoxicam—Headache—Lisinopril—systemic scleroderma	0.000813	0.0013	CcSEcCtD
Tenoxicam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000804	0.00129	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000798	0.00128	CcSEcCtD
Tenoxicam—Mental disorder—Methotrexate—systemic scleroderma	0.000794	0.00127	CcSEcCtD
Tenoxicam—Malnutrition—Methotrexate—systemic scleroderma	0.000789	0.00126	CcSEcCtD
Tenoxicam—Erythema—Methotrexate—systemic scleroderma	0.000789	0.00126	CcSEcCtD
Tenoxicam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000778	0.00125	CcSEcCtD
Tenoxicam—Nausea—Lisinopril—systemic scleroderma	0.00077	0.00124	CcSEcCtD
Tenoxicam—Anaphylactic shock—Prednisone—systemic scleroderma	0.00077	0.00124	CcSEcCtD
Tenoxicam—Oedema—Prednisone—systemic scleroderma	0.00077	0.00124	CcSEcCtD
Tenoxicam—Nervous system disorder—Prednisone—systemic scleroderma	0.000755	0.00121	CcSEcCtD
Tenoxicam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000752	0.00121	CcSEcCtD
Tenoxicam—Skin disorder—Prednisone—systemic scleroderma	0.000748	0.0012	CcSEcCtD
Tenoxicam—Anorexia—Prednisone—systemic scleroderma	0.000734	0.00118	CcSEcCtD
Tenoxicam—Anaemia—Methotrexate—systemic scleroderma	0.000729	0.00117	CcSEcCtD
Tenoxicam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000723	0.00116	CcSEcCtD
Tenoxicam—Rash—Mycophenolate mofetil—systemic scleroderma	0.000717	0.00115	CcSEcCtD
Tenoxicam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00115	CcSEcCtD
Tenoxicam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000712	0.00114	CcSEcCtD
Tenoxicam—Vertigo—Methotrexate—systemic scleroderma	0.000709	0.00114	CcSEcCtD
Tenoxicam—Leukopenia—Methotrexate—systemic scleroderma	0.000706	0.00113	CcSEcCtD
Tenoxicam—Dyspepsia—Prednisone—systemic scleroderma	0.000678	0.00109	CcSEcCtD
Tenoxicam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000675	0.00108	CcSEcCtD
Tenoxicam—Decreased appetite—Prednisone—systemic scleroderma	0.00067	0.00107	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000667	0.00107	CcSEcCtD
Tenoxicam—Fatigue—Prednisone—systemic scleroderma	0.000664	0.00107	CcSEcCtD
Tenoxicam—Constipation—Prednisone—systemic scleroderma	0.000659	0.00106	CcSEcCtD
Tenoxicam—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000644	0.00103	CcSEcCtD
Tenoxicam—Nervous system disorder—Methotrexate—systemic scleroderma	0.000631	0.00101	CcSEcCtD
Tenoxicam—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00063	0.00101	CcSEcCtD
Tenoxicam—Skin disorder—Methotrexate—systemic scleroderma	0.000625	0.001	CcSEcCtD
Tenoxicam—Anorexia—Methotrexate—systemic scleroderma	0.000614	0.000984	CcSEcCtD
Tenoxicam—Urticaria—Prednisone—systemic scleroderma	0.000612	0.000981	CcSEcCtD
Tenoxicam—Dyspnoea—Methotrexate—systemic scleroderma	0.000574	0.00092	CcSEcCtD
Tenoxicam—Hypersensitivity—Prednisone—systemic scleroderma	0.000568	0.00091	CcSEcCtD
Tenoxicam—Dyspepsia—Methotrexate—systemic scleroderma	0.000567	0.000909	CcSEcCtD
Tenoxicam—Decreased appetite—Methotrexate—systemic scleroderma	0.00056	0.000897	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000556	0.000891	CcSEcCtD
Tenoxicam—Fatigue—Methotrexate—systemic scleroderma	0.000555	0.00089	CcSEcCtD
Tenoxicam—Asthenia—Prednisone—systemic scleroderma	0.000553	0.000886	CcSEcCtD
Tenoxicam—Pruritus—Prednisone—systemic scleroderma	0.000545	0.000874	CcSEcCtD
Tenoxicam—Diarrhoea—Prednisone—systemic scleroderma	0.000527	0.000845	CcSEcCtD
Tenoxicam—Urticaria—Methotrexate—systemic scleroderma	0.000511	0.00082	CcSEcCtD
Tenoxicam—Dizziness—Prednisone—systemic scleroderma	0.000509	0.000817	CcSEcCtD
Tenoxicam—Vomiting—Prednisone—systemic scleroderma	0.00049	0.000785	CcSEcCtD
Tenoxicam—Rash—Prednisone—systemic scleroderma	0.000486	0.000779	CcSEcCtD
Tenoxicam—Dermatitis—Prednisone—systemic scleroderma	0.000485	0.000778	CcSEcCtD
Tenoxicam—Headache—Prednisone—systemic scleroderma	0.000483	0.000774	CcSEcCtD
Tenoxicam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000474	0.000761	CcSEcCtD
Tenoxicam—Asthenia—Methotrexate—systemic scleroderma	0.000462	0.000741	CcSEcCtD
Tenoxicam—Nausea—Prednisone—systemic scleroderma	0.000458	0.000734	CcSEcCtD
Tenoxicam—Pruritus—Methotrexate—systemic scleroderma	0.000456	0.00073	CcSEcCtD
Tenoxicam—Diarrhoea—Methotrexate—systemic scleroderma	0.000441	0.000706	CcSEcCtD
Tenoxicam—Dizziness—Methotrexate—systemic scleroderma	0.000426	0.000683	CcSEcCtD
Tenoxicam—Vomiting—Methotrexate—systemic scleroderma	0.000409	0.000656	CcSEcCtD
Tenoxicam—Rash—Methotrexate—systemic scleroderma	0.000406	0.000651	CcSEcCtD
Tenoxicam—Dermatitis—Methotrexate—systemic scleroderma	0.000406	0.00065	CcSEcCtD
Tenoxicam—Headache—Methotrexate—systemic scleroderma	0.000403	0.000647	CcSEcCtD
Tenoxicam—Nausea—Methotrexate—systemic scleroderma	0.000382	0.000613	CcSEcCtD
